Sun Pharmaceutical Industries Limited SUNPHARMA.NS · Stock Open Sun Pharmaceutical Industries Limited in new tab
Sun Pharmaceutical Industries Limited Analysis (SUNPHARMA.NS)
Is Sun Pharmaceutical Industries Limited a good investment? Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) is currently trading at 1871.00 INR. Market analysts have a consensus price target of 2047.35 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 38.97. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Sun Pharmaceutical Industries Limited is expected to release its next earnings report on July 30, 2026. The market consensus estimate for Forward EPS is 64.67.
For income investors, Sun Pharmaceutical Industries Limited pays a dividend yield of 0.88%. With a payout ratio of 11%, the dividend appears sustainable.
Investor FAQ
Does Sun Pharmaceutical Industries Limited pay a dividend?
Yes, it pays an annual dividend of 16.50 INR (0.88% yield).
What asset class is Sun Pharmaceutical Industries Limited?
Sun Pharmaceutical Industries Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be July 30, 2026. The company currently has a trailing EPS of 47.80.
Company Profile
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respiratory, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. It exports its products to approximately 90 countries across Asia, North America, Europe, Africa, South America, and Australia. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2027 |
17.08 INR
|
| Feb. 23, 2027 (estimated) | 17.0833 |
| ▸2026 |
16.00 INR
|
| Aug. 7, 2026 | 5.0000 |
| Feb. 12, 2026 | 11.0000 |
| ▸2025 |
16.00 INR
|
| Aug. 1, 2025 | 5.5000 |
| Feb. 20, 2025 | 10.5000 |
| ▸2024 |
13.50 INR
|
| Aug. 16, 2024 | 5.0000 |
| Feb. 23, 2024 | 8.5000 |
| ▸2023 |
11.50 INR
|
| Sept. 8, 2023 | 4.0000 |
| March 2, 2023 | 7.5000 |
| ▸2022 |
10.00 INR
|
| Sept. 20, 2022 | 3.0000 |
| Feb. 22, 2022 | 7.0000 |
| ▸2021 |
7.50 INR
|
| Sept. 17, 2021 | 2.0000 |
| Feb. 19, 2021 | 5.5000 |
| ▸2020 |
4.00 INR
|
| Sept. 1, 2020 | 1.0000 |
| Feb. 24, 2020 | 3.0000 |
| ▸2019 |
2.75 INR
|
| Aug. 30, 2019 | 2.7500 |
| ▸2018 |
2.00 INR
|
| Oct. 1, 2018 | 2.0000 |
| ▸2017 |
3.50 INR
|
| Oct. 26, 2017 | 3.5000 |
| ▸2016 |
1.00 INR
|
| Oct. 17, 2016 | 1.0000 |
| ▸2015 |
3.00 INR
|
| Nov. 30, 2015 | 3.0000 |
| ▸2014 |
1.50 INR
|
| Sept. 30, 2014 | 1.5000 |
| ▸2013 |
2.50 INR
|
| Oct. 30, 2013 | 2.5000 |
| ▸2012 |
2.13 INR
|
| Sept. 9, 2012 | 2.1250 |
| ▸2011 |
1.75 INR
|
| Oct. 16, 2011 | 1.7500 |
| ▸2010 |
1.38 INR
|
| Oct. 24, 2010 | 1.3750 |
| ▸2009 |
1.38 INR
|
| Oct. 1, 2009 | 1.3750 |
| ▸2008 |
1.05 INR
|
| Oct. 1, 2008 | 1.0500 |
| ▸2007 |
0.68 INR
|
| March 31, 2007 | 0.6750 |
| ▸2006 |
0.55 INR
|
| Sept. 23, 2006 | 0.5500 |
| ▸2005 |
0.38 INR
|
| Oct. 6, 2005 | 0.3750 |
| ▸2004 |
0.33 INR
|
| Dec. 29, 2004 | 0.3250 |
| ▸2003 |
0.25 INR
|
| Oct. 11, 2003 | 0.2500 |
| ▸2002 |
0.13 INR
|
| Sept. 7, 2002 | 0.1250 |
| ▸2001 |
0.13 INR
|
| Sept. 1, 2001 | 0.1250 |
| ▸2000 |
0.10 INR
|
| March 8, 2000 | 0.0333 |
| Jan. 1, 2000 | 0.0667 |
| ▸1999 |
0.05 INR
|
| July 1, 1999 | 0.0500 |
| ▸1998 |
0.05 INR
|
| Aug. 1, 1998 | 0.0500 |
| ▸1997 |
0.03 INR
|
| Aug. 27, 1997 | 0.0292 |
| ▸1996 |
0.02 INR
|
| Aug. 1, 1996 | 0.0208 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Aug 07, 2026 | Upcoming | 5.0 INR |
| Sun Pharmaceutical Industries Limited | Feb 12, 2026 | Paid | 11.0 INR |
| Sun Pharmaceutical Industries Limited | Aug 01, 2025 | Paid | 5.5 INR |
| Split Date | Split Ratio to 1 |
|---|---|
| March 8, 2000 | 3.000000 |
| Jan. 13, 2003 | 2.000000 |
| May 27, 2004 | 2.000000 |
| Nov. 25, 2010 | 5.000000 |
| July 29, 2013 | 2.000000 |
Community Discussion